← Eichor
Condition: High Risk Human Papillomavirus Infection Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: High Risk Human Papillomavirus Infection

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Observational Study of Viral BIOmarkers and microRNAs in Tumors Orofarynx and Occult Tumors Positive for Papilloma Virus
Phase N/A · 1 location(s) · Regina Elena Cancer Institute · NCT05918510
Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytolo
Phase 2 · 1 location(s) · Amplexd Therapeutics, Inc. · NCT07572396
HUC-MSC for Treatment of High-risk HPV Infection
Phase 1/Phase 2 · 1 location(s) · Shanghai East Hospital · NCT06610773
A Study to Assess the Reduction of Human Papillomavirus (HPV) Viral Infectivity and Transmission in HPV-Positive Women A
Phase 4 · 1 location(s) · Miquel Angel Pavon Ribas · NCT05334706
Anal Cancer and/or Precancer Screening: Performance Analysis of the BD Onclarity™ HPV Assay on Anal Specimens
Phase N/A · 1 location(s) · European Institute of Oncology · NCT06327568
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants W
Phase 1/Phase 2 · 32 location(s) · Marengo Therapeutics, Inc. · NCT05592626
Human Papillomavirus Self-sampling for Enhancing Cervical Screening During the War in Ukraine
NA · 1 location(s) · Karolinska Institutet · NCT07275333
Multi-site HPV Screening by High-throughput Sequencing in Patients With Chronic HPV-HR Infection Followed by Gynecology
NA · 1 location(s) · University Hospital, Toulouse · NCT04901351
Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer
NA · 3 location(s) · Qurasense · NCT07281599
Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HS
Phase 2 · 5 location(s) · Frantz Viral Therapeutics, LLC · NCT06075264
Global Burden Estimation of Human Papillomavirus (GLOBE-HPV)
Phase N/A · 8 location(s) · International Vaccine Institute · NCT06129253
Non-Invasive Plasma Treatment for Cervical Infections: Targeting High- and Low-Risk HPV Variants
Phase N/A · 1 location(s) · University Hospital Tuebingen · NCT06291311
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.